Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-22

FDA Approved: PERPHENAZINE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for PERPHENAZINE filed by Rising Pharma Holdings, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PERPHENAZINE (Perphenazine)

Snippet

SUPPL AP for PERPHENAZINE (PERPHENAZINE)